PubMed:32335561
Annnotations
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-31 | SP_7 | denotes | COVID-19 |
| T2 | 98-106 | SP_7 | denotes | COVID-19 |
| T3 | 235-240 | NCBITaxon:10239 | denotes | virus |
| T4 | 253-269 | CHEBI:22587 | denotes | antiviral agents |
| T5 | 253-269 | CHEBI:22587 | denotes | antiviral agents |
| T6 | 301-312 | NCBITaxon:11118 | denotes | coronavirus |
| T7 | 332-336 | SP_10 | denotes | SARS |
| T8 | 341-345 | SP_9 | denotes | MERS |
| T9 | 410-418 | SP_7 | denotes | COVID-19 |
| T10 | 748-756 | SP_7 | denotes | COVID-19 |
| T11 | 915-923 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 23-31 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 98-106 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 187-196 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T4 | 313-323 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T5 | 332-336 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T6 | 410-418 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T7 | 748-756 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T8 | 915-923 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 218-228 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | are facing |
| T2 | 229-230 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T3 | 235-240 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T4 | 643-644 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 253-269 | Chemical | denotes | antiviral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1 | 23-31 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 9 | 98-106 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 10 | 301-323 | Disease | denotes | coronavirus infections | MESH:D018352 |
| 11 | 332-336 | Disease | denotes | SARS | MESH:D045169 |
| 12 | 341-345 | Disease | denotes | MERS | MESH:D018352 |
| 13 | 410-418 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 14 | 748-756 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 15 | 915-923 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-93 | Sentence | denotes | Update on treatment of COVID-19: ongoing studies between promising and disappointing results. |
| T2 | 94-214 | Sentence | denotes | The COVID-19 pandemic represents the greatest global public health crisis since the pandemic influenza outbreak of 1918. |
| T3 | 215-419 | Sentence | denotes | We are facing a new virus, so several antiviral agents previously used to treat other coronavirus infections such as SARS and MERS are being considered as the first potential candidates to treat COVID-19. |
| T4 | 420-624 | Sentence | denotes | Thus, several agents have been used by the beginning of the current outbreak in China first and all over the word successively, as reported in several different guidelines and therapeutic recommendations. |
| T5 | 625-838 | Sentence | denotes | At the same time, a great number of clinical trials have been launched to investigate the potential efficacy therapies for COVID-19 highlighting the urgent need to get as quickly as possible high-quality evidence. |
| T6 | 839-967 | Sentence | denotes | Through PubMed, we explored the relevant articles published on treatment of COVID-19 and on trials ongoing up to April 15, 2020. |